The incidence and prevalence of CTD-ILD significantly impact adults in the US, particularly older patients and women.
According to study results presented at the American College of Rheumatology (ACR) Convergence 2025, CTD-ILD imparts a major healthcare burden on adult patients in the US, especially women and older individuals.
CTD-ILD is linked to reduced quality of life and premature mortality.
Researchers examined the occurrence of CTD-ILD in the US, using data from the Optum de-identified electronic health record data set and the MarketScan Commercial and Medicare Databases.
Author's summary: CTD-ILD affects older patients and women significantly.